Strategic Diagnostics is a biotechnology company delivering advanced immuno-solutions and critical reagents to the life science industry. The company also makes products for the food safety industry. Its rapid detection solutions for the $1 billion food pathogen testing market helps its customers reduce time, labor and costs while increasing accuracy and reliability of food pathogen detection.
The company announced today that its RapidChek SELECT Salmonella Enteritidis test system has been thoroughly reviewed by the US Food and Drug Administration (FDA). It was determined to be equivalent in accuracy, precision and sensitivity to their current standard methods for poultry house environmental drag swabs and pooled egg testing.
For pooled egg testing, SDIX’s method is considered by the FDA as equivalent to its standard test without a 96-hour hold period, thus delivering results with a substantial time and cost advantage. Recently, SDIX’s test system also received certification from the AOAC Research Institute, which validated the company’s method as equivalent to the FDA methodology.
This is an important market. According to the US Department of Agriculture and the Center for Disease Control’s FoodNet surveillance system, salmonella is the most common food-borne bacterial pathogen with over 1 million estimated cases in the US. In addition, salmonella is responsible for more hospitalizations and more deaths – about 400 annually – than any other food pathogen.
SDIX’s test can help the approximate 3,300 US egg producers comply with the new FDA regulations brought about by all the recent egg recalls. The company’s test system will also significantly reduce contamination levels from those being experienced today by providing a more sensitive and accurate detection of salmonella enteritidis.
For more information about SDIX, please visit the company’s website at www.sdix.com